TY - JOUR
T1 - Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer
AU - Yamamoto, Hirofumi
AU - Tei, Mitsuyoshi
AU - Uemura, Mamoru
AU - Takemasa, Ichiro
AU - Uemura, Yoshio
AU - Murata, Kohei
AU - Fukunaga, Mutsumi
AU - Ohue, Masayuki
AU - Ohnishi, Tadashi
AU - Ikeda, Kimimasa
AU - Kato, Takeshi
AU - Okamura, Shu
AU - Ikenaga, Masakazu
AU - Haraguchi, Naotsugu
AU - Nishimura, Junichi
AU - Mizushima, Tsunekazu
AU - Mimori, Koshi
AU - Doki, Yuichiro
AU - Mori, Masaki
PY - 2013/2
Y1 - 2013/2
N2 - We previously studied hypoxic tumor cells from hepatic metastases of colorectal cancer (CRC) and determined several potential prognostic factors, including expression of ephrin-A1 (EFNA1), which was highly induced by hypoxia. Here, we further evaluated the prognostic impact of EFNA1 expression. Samples from a total of 366 CRC patients from 11 institutes were analyzed by either microarray (n=220) or quantitative reverse-transcriptase polymerase chain reaction (n=146). EFNA1 was an independent prognostic factor for CRC (p<0.05). In vitro assays revealed that loss of EFNA1 following siRNA treatment was associated with reduced proliferative activity and decreased invasion and migration of CRC cell lines. EFNA1 expression is a useful marker for predicting high risk of relapse and cancer-related death in patients who have undergone curative resection for CRC.
AB - We previously studied hypoxic tumor cells from hepatic metastases of colorectal cancer (CRC) and determined several potential prognostic factors, including expression of ephrin-A1 (EFNA1), which was highly induced by hypoxia. Here, we further evaluated the prognostic impact of EFNA1 expression. Samples from a total of 366 CRC patients from 11 institutes were analyzed by either microarray (n=220) or quantitative reverse-transcriptase polymerase chain reaction (n=146). EFNA1 was an independent prognostic factor for CRC (p<0.05). In vitro assays revealed that loss of EFNA1 following siRNA treatment was associated with reduced proliferative activity and decreased invasion and migration of CRC cell lines. EFNA1 expression is a useful marker for predicting high risk of relapse and cancer-related death in patients who have undergone curative resection for CRC.
UR - http://www.scopus.com/inward/record.url?scp=84873658823&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873658823&partnerID=8YFLogxK
U2 - 10.3892/ijo.2012.1750
DO - 10.3892/ijo.2012.1750
M3 - Article
C2 - 23258614
AN - SCOPUS:84873658823
VL - 42
SP - 549
EP - 555
JO - International Journal of Oncology
JF - International Journal of Oncology
SN - 1019-6439
IS - 2
ER -
